Peptron

Peptron Aims for "Comfortable Healing," which signifies better compliance, enabling patients to achieve improved treatment more easily and thus cure diseases. Since its establishment in 1997, Peptron Inc. has been developing platform technologies for peptide-based drugs. Based on proprietary technology, the company is developing sustained-release drugs with high technical entry barriers and excellent product competitiveness. SmartDepot™ is its most representative technology; SmartDepot™ is a unique technology specifically designed for the gradual release of drugs. After a single injection, the drug is released gradually over a specific period. When applied to various peptide-based or small molecule drugs that require once or multiple daily injections, SmartDepot™ will significantly enhance patient convenience and treatment efficacy.